 | • レポートコード：GIR-105X15200 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ビブライド（ビラゾドン）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ビブライド（ビラゾドン）の種類別市場規模（10mg、20mg、40mg）、用途別市場規模（うつ病、不安、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ビブライド（ビラゾドン）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan plc (AbbVie Inc.)、Actavis Generics (Teva)、Clinical Data, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10mg、20mg、40mg ・用途別分析2016年-2026年：うつ病、不安、その他 ・ビブライド（ビラゾドン）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ビブライド（ビラゾドン）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ビブライド（ビラゾドン）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ビブライド（ビラゾドン）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ビブライド（ビラゾドン）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Viibryd (Vilazodone) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Viibryd (Vilazodone) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Viibryd (Vilazodone) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Viibryd (Vilazodone) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 mg
20 mg
40 mg
Market segment by Application can be divided into
Major Depression
Anxiety
Others
The key market players for global Viibryd (Vilazodone) market are listed below:
Allergan plc (AbbVie Inc.)
Actavis Generics (Teva)
Clinical Data, Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Viibryd (Vilazodone) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Viibryd (Vilazodone) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10 mg
1.2.3 20 mg
1.2.4 40 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Viibryd (Vilazodone) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Major Depression
1.3.3 Anxiety
1.3.4 Others
1.4 Global Viibryd (Vilazodone) Market Size & Forecast
1.4.1 Global Viibryd (Vilazodone) Sales in Value (2016-2026))
1.4.2 Global Viibryd (Vilazodone) Sales in Volume (2016-2026)
1.4.3 Global Viibryd (Vilazodone) Price by Type (2016-2026) & (US$/Unit)
1.5 Global Viibryd (Vilazodone) Production Capacity Analysis
1.5.1 Global Viibryd (Vilazodone) Total Production Capacity (2016-2026)
1.5.2 Global Viibryd (Vilazodone) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Viibryd (Vilazodone) Market Drivers
1.6.2 Viibryd (Vilazodone) Market Restraints
1.6.3 Viibryd (Vilazodone) Trends Analysis
2 Manufacturers Profiles
2.1 Allergan plc (AbbVie Inc.)
2.1.1 Allergan plc (AbbVie Inc.) Details
2.1.2 Allergan plc (AbbVie Inc.) Major Business
2.1.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product and Services
2.1.4 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Actavis Generics (Teva)
2.2.1 Actavis Generics (Teva) Details
2.2.2 Actavis Generics (Teva) Major Business
2.2.3 Actavis Generics (Teva) Viibryd (Vilazodone) Product and Services
2.2.4 Actavis Generics (Teva) Viibryd (Vilazodone) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Clinical Data, Inc.
2.3.1 Clinical Data, Inc. Details
2.3.2 Clinical Data, Inc. Major Business
2.3.3 Clinical Data, Inc. Viibryd (Vilazodone) Product and Services
2.3.4 Clinical Data, Inc. Viibryd (Vilazodone) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Viibryd (Vilazodone) Sales by Manufacturer
3.1 Global Viibryd (Vilazodone) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Viibryd (Vilazodone) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Viibryd (Vilazodone)
3.4 Market Concentration Rate
3.4.1 Top 3 Viibryd (Vilazodone) Manufacturer Market Share
3.4.2 Top 6 Viibryd (Vilazodone) Manufacturer Market Share
3.5 Global Viibryd (Vilazodone) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Viibryd (Vilazodone) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Viibryd (Vilazodone) Market Size by Region
4.1.1 Global Viibryd (Vilazodone) Sales in Volume by Region (2016-2026)
4.1.2 Global Viibryd (Vilazodone) Revenue by Region (2016-2026)
4.2 North America Viibryd (Vilazodone) Revenue (2016-2026)
4.3 Europe Viibryd (Vilazodone) Revenue (2016-2026)
4.4 Asia-Pacific Viibryd (Vilazodone) Revenue (2016-2026)
4.5 South America Viibryd (Vilazodone) Revenue (2016-2026)
4.6 Middle East and Africa Viibryd (Vilazodone) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Viibryd (Vilazodone) Sales in Volume by Type (2016-2026)
5.2 Global Viibryd (Vilazodone) Revenue by Type (2016-2026)
5.3 Global Viibryd (Vilazodone) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Viibryd (Vilazodone) Sales in Volume by Application (2016-2026)
6.2 Global Viibryd (Vilazodone) Revenue by Application (2016-2026)
6.3 Global Viibryd (Vilazodone) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Viibryd (Vilazodone) Sales by Type (2016-2026)
7.2 North America Viibryd (Vilazodone) Sales by Application (2016-2026)
7.3 North America Viibryd (Vilazodone) Market Size by Country
7.3.1 North America Viibryd (Vilazodone) Sales in Volume by Country (2016-2026)
7.3.2 North America Viibryd (Vilazodone) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Viibryd (Vilazodone) Sales by Type (2016-2026)
8.2 Europe Viibryd (Vilazodone) Sales by Application (2016-2026)
8.3 Europe Viibryd (Vilazodone) Market Size by Country
8.3.1 Europe Viibryd (Vilazodone) Sales in Volume by Country (2016-2026)
8.3.2 Europe Viibryd (Vilazodone) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Viibryd (Vilazodone) Sales by Type (2016-2026)
9.2 Asia-Pacific Viibryd (Vilazodone) Sales by Application (2016-2026)
9.3 Asia-Pacific Viibryd (Vilazodone) Market Size by Region
9.3.1 Asia-Pacific Viibryd (Vilazodone) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Viibryd (Vilazodone) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Viibryd (Vilazodone) Sales by Type (2016-2026)
10.2 South America Viibryd (Vilazodone) Sales by Application (2016-2026)
10.3 South America Viibryd (Vilazodone) Market Size by Country
10.3.1 South America Viibryd (Vilazodone) Sales in Volume by Country (2016-2026)
10.3.2 South America Viibryd (Vilazodone) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Viibryd (Vilazodone) Sales by Type (2016-2026)
11.2 Middle East & Africa Viibryd (Vilazodone) Sales by Application (2016-2026)
11.3 Middle East & Africa Viibryd (Vilazodone) Market Size by Country
11.3.1 Middle East & Africa Viibryd (Vilazodone) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Viibryd (Vilazodone) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Viibryd (Vilazodone) Typical Distributors
12.3 Viibryd (Vilazodone) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Viibryd (Vilazodone) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Viibryd (Vilazodone) Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan plc (AbbVie Inc.) Basic Information, Manufacturing Base and Competitors
Table 4. Allergan plc (AbbVie Inc.) Major Business
Table 5. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product and Services
Table 6. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Actavis Generics (Teva) Basic Information, Manufacturing Base and Competitors
Table 8. Actavis Generics (Teva) Major Business
Table 9. Actavis Generics (Teva) Viibryd (Vilazodone) Product and Services
Table 10. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Clinical Data, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Clinical Data, Inc. Major Business
Table 13. Clinical Data, Inc. Viibryd (Vilazodone) Product and Services
Table 14. Clinical Data, Inc. Viibryd (Vilazodone) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Viibryd (Vilazodone) Sales by Manufacturer (2019-2021e) & (K Units)
Table 16. Global Viibryd (Vilazodone) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Viibryd (Vilazodone), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Viibryd (Vilazodone) Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Viibryd (Vilazodone) Production Site of Key Manufacturer
Table 20. Global Viibryd (Vilazodone) Sales by Region (2016-2021e) & (K Units)
Table 21. Global Viibryd (Vilazodone) Sales by Region (2021-2026) & (K Units)
Table 22. Global Viibryd (Vilazodone) Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Viibryd (Vilazodone) Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 25. Global Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 26. Global Viibryd (Vilazodone) Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Viibryd (Vilazodone) Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Viibryd (Vilazodone) Price by Type (2016-2021e) & (US$/Unit)
Table 29. Global Viibryd (Vilazodone) Price by Type (2021-2026) & (US$/Unit)
Table 30. Global Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 31. Global Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 32. Global Viibryd (Vilazodone) Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Viibryd (Vilazodone) Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Viibryd (Vilazodone) Price by Application (2016-2021e) & (US$/Unit)
Table 35. Global Viibryd (Vilazodone) Price by Application (2021-2026) & (US$/Unit)
Table 36. North America Viibryd (Vilazodone) Sales by Country (2016-2021e) & (K Units)
Table 37. North America Viibryd (Vilazodone) Sales by Country (2021-2026) & (K Units)
Table 38. North America Viibryd (Vilazodone) Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Viibryd (Vilazodone) Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 41. North America Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 42. North America Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 43. North America Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 44. Europe Viibryd (Vilazodone) Sales by Country (2016-2021e) & (K Units)
Table 45. Europe Viibryd (Vilazodone) Sales by Country (2021-2026) & (K Units)
Table 46. Europe Viibryd (Vilazodone) Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Viibryd (Vilazodone) Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 49. Europe Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 50. Europe Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 51. Europe Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 52. Asia-Pacific Viibryd (Vilazodone) Sales by Region (2016-2021e) & (K Units)
Table 53. Asia-Pacific Viibryd (Vilazodone) Sales by Region (2021-2026) & (K Units)
Table 54. Asia-Pacific Viibryd (Vilazodone) Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Viibryd (Vilazodone) Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 57. Asia-Pacific Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 58. Asia-Pacific Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 59. Asia-Pacific Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 60. South America Viibryd (Vilazodone) Sales by Country (2016-2021e) & (K Units)
Table 61. South America Viibryd (Vilazodone) Sales by Country (2021-2026) & (K Units)
Table 62. South America Viibryd (Vilazodone) Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Viibryd (Vilazodone) Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 65. South America Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 66. South America Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 67. South America Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Viibryd (Vilazodone) Sales by Country (2016-2021e) & (K Units)
Table 69. Middle East & Africa Viibryd (Vilazodone) Sales by Country (2021-2026) & (K Units)
Table 70. Middle East & Africa Viibryd (Vilazodone) Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Viibryd (Vilazodone) Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Viibryd (Vilazodone) Sales by Type (2016-2021e) & (K Units)
Table 73. Middle East & Africa Viibryd (Vilazodone) Sales by Type (2021-2026) & (K Units)
Table 74. Middle East & Africa Viibryd (Vilazodone) Sales by Application (2016-2021e) & (K Units)
Table 75. Middle East & Africa Viibryd (Vilazodone) Sales by Application (2021-2026) & (K Units)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Viibryd (Vilazodone) Typical Distributors
Table 79. Viibryd (Vilazodone) Typical Customers
List of Figures
Figure 1. Viibryd (Vilazodone) Picture
Figure 2. Global Viibryd (Vilazodone) Sales Market Share by Type in 2020
Figure 3. 10 mg
Figure 4. 20 mg
Figure 5. 40 mg
Figure 6. Global Viibryd (Vilazodone) Sales Market Share by Application in 2020
Figure 7. Major Depression
Figure 8. Anxiety
Figure 9. Others
Figure 10. Global Viibryd (Vilazodone) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Viibryd (Vilazodone) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Viibryd (Vilazodone) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Viibryd (Vilazodone) Sales (2016-2026) & (K Units)
Figure 32. Global Viibryd (Vilazodone) Production Capacity (2016-2026) & (K Units)
Figure 33. Global Viibryd (Vilazodone) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Viibryd (Vilazodone) Market Drivers
Figure 35. Viibryd (Vilazodone) Market Restraints
Figure 36. Viibryd (Vilazodone) Market Trends
Figure 37. Global Viibryd (Vilazodone) Sales Market Share by Manufacturer in 2020
Figure 38. Global Viibryd (Vilazodone) Revenue Market Share by Manufacturer in 2020
Figure 39. Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Viibryd (Vilazodone) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Viibryd (Vilazodone) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Viibryd (Vilazodone) Sales Market Share by Region (2016-2026)
Figure 43. Global Viibryd (Vilazodone) Revenue Market Share by Region (2016-2026)
Figure 44. North America Viibryd (Vilazodone) Revenue (2016-2026) & (USD Million)
Figure 45. Europe Viibryd (Vilazodone) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Viibryd (Vilazodone) Revenue (2016-2026) & (USD Million)
Figure 47. South America Viibryd (Vilazodone) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Viibryd (Vilazodone) Revenue (2016-2026) & (USD Million)
Figure 49. Global Viibryd (Vilazodone) Sales Market Share by Type (2016-2026)
Figure 50. Global Viibryd (Vilazodone) Revenue Market Share by Type (2016-2026)
Figure 51. Global Viibryd (Vilazodone) Price by Type (2016-2026) & (US$/Unit)
Figure 52. Global Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 53. Global Viibryd (Vilazodone) Revenue Market Share by Application (2016-2026)
Figure 54. Global Viibryd (Vilazodone) Price by Application (2016-2026) & (US$/Unit)
Figure 55. North America Viibryd (Vilazodone) Sales Market Share by Country (2016-2026)
Figure 56. North America Viibryd (Vilazodone) Revenue Market Share by Country (2016-2026)
Figure 57. North America Viibryd (Vilazodone) Sales Market Share by Type (2016-2026)
Figure 58. North America Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 59. Europe Viibryd (Vilazodone) Sales Market Share by Country (2016-2026)
Figure 60. Europe Viibryd (Vilazodone) Revenue Market Share by Country (2016-2026)
Figure 61. Europe Viibryd (Vilazodone) Sales Market Share by Type (2016-2026)
Figure 62. Europe Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Viibryd (Vilazodone) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Viibryd (Vilazodone) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Viibryd (Vilazodone) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 67. South America Viibryd (Vilazodone) Sales Market Share by Country (2016-2026)
Figure 68. South America Viibryd (Vilazodone) Revenue Market Share by Country (2016-2026)
Figure 69. South America Viibryd (Vilazodone) Sales Market Share by Type (2016-2026)
Figure 70. South America Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Viibryd (Vilazodone) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Viibryd (Vilazodone) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Viibryd (Vilazodone) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Viibryd (Vilazodone) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
不安とパニック障害薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anxiety and Panic Disorders Drugs are two kinds of drugs which are usually used in respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal. Scope of the Report: This report focuses on the Anxiety and Panic Disorders D…- 世界のボルチオキセチン市場 2021：企業別、地域別、種類・用途別 The Vortioxetine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界の頭蓋電気療法刺激装置（CES）デバイス市場 2021：企業別、地域別、種類・用途別 The Cranial Electrotherapy Stimulator (CES) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界のオープンセル・クローズドセル用フェノールフォーム市場 2021：企業別、地域別、種類・用途別 The Open Versus Closed Cell Phenolic Foams market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のLED式PAR缶市場 2021：企業別、地域別、種類・用途別 The LED PAR Cans market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…